Company / Shareholders' Equity
Celularity Inc Shareholders' Equity History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$38.1M
FY2025
5-year range
-$38.1M / $198.9M
FY2021-FY2025
Trend
-530.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Celularity Inc reports negative total equity of -$38M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$38M in FY2025.
Declined from $41M to -$38M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Celularity Inc's shareholders' equity has declined for 3 consecutive years.
- In FY2025, shareholders' equity decreased 530.7% year-over-year.
- Peak shareholders' equity was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$38.1M | -530.7% |
| FY2024 | $8.8M | -78.4% |
| FY2023 | $41.0M | -79.4% |
| FY2022 | $198.9M | +100.1% |
| FY2021 | $99.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026